Composition(s) and method(s) for topically treating pain
OwnerRobert Alonso, Lawrence G. Stollinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerRobert Alonso, Lawrence G. Stollinventors
Estimating the term…
Pharmaceutically effective compositions and methods for topically treating pain due to swelling or inflammation of fascia, tendons, or ligaments in a patient in need of treatment, thereof. The pharmaceutically effective composition consists essentially of: 68.6-29.4 parts by weight of a pharmaceutically acceptable excipient; 40.0-50.0 parts by weight DMSO; 1.0-5.0 parts by weight of an anesthetic, wherein the anesthetic is advantageously characterized as containing only lidocaine; and 1.2-3.2 parts by weight of an anti-inflammatory in 100 parts by weight of the pharmaceutically effective composition. In one embodiment, the anesthetic is advantageously 4.0 parts by weight Lidocaine. In one embodiment, the pharmaceutically acceptable excipient is 48.0 parts by weight, DMSO is 45 parts by weight, anesthetic is advantageously 4.0 parts by weight Lidocaine, Echinaceas is 1.0 part by weight and Arnica is 1.0 part by weight, and the condition causing pain of the foot is Plantar Fasciitis.
A method for topically treating a condition causing pain due to swelling inflammation of fascia, tendons, or ligaments of a patient in need of treatment thereof, comprising:
The method of any one of the preceding claims, wherein the pharmaceutically acceptable excipient comprises 0.6-1.6 parts by weight hydroxypropyl cellulose NF, resulting in a viscosity of the composition being from about 18,000 cps to about 42,000 cps at 20° C.
Dependencies are inferred from the claim text.